Practical Neurology

07/11/2025

The U.S. Food and Drug Administration approved an update to ’s ( ) label to include a new titration schedule that lowers -E risk without compromising efficacy.
https://ow.ly/2mY150WoxQe
Eli Lilly and Company Alzheimer's Association American Academy of Neurology (AAN)

The Food and Drug Administration (FDA) has approved a new titration dosing schedule for Kisunla (donanemab-azbt; Eli Lilly and Company, Indianapolis, IN),…

07/11/2025

Breast cancer survivors—especially those who were older and those treated with radiation therapy—had a slightly lower risk of disease in results published in JAMA Network Open.
https://ow.ly/9IEl50Wo2sI
Alzheimer's Association American Academy of Neurology (AAN) National Breast Cancer Foundation American College of Physicians (ACP) Society for Neuro-Oncology, USA

Breast cancer survivors had a slightly lower risk of Alzheimer disease (AD) compared with women without breast cancer, particularly among older survivor…

07/10/2025

Read about a rare case of bilateral temporalis muscle hypertrophy presenting with and facial pain, managed with injections. New report authored by Drs. Herath, Lutchman, Saleh, Naidu, and Wimalaratna at Kettering General Hospital.
https://ow.ly/nmEz50Wnipl

American Headache Society®

07/10/2025

Intra-arterial after successful improved 90-day outcomes without added risk in people with large vessel occlusion, according to data published in JAMA.
https://ow.ly/IwlH50WnmKS

American Academy of Neurology (AAN) American Heart Association Endovascular Today

Adjunct intra-arterial TNKase (tenecteplase; Genentech, South San Francisco, CA) was associated with significant improvements in 90-day functional outcome…

07/10/2025

The U.S. Food and Drug Administration has cleared the Felix NeuroAI Wristband—a noninvasive wearable device to treat .
https://ow.ly/ce2T50WnmaI

American Academy of Neurology (AAN) International Parkinson and Movement Disorder Society International Essential Tremor Foundation

07/09/2025

The U.S. Food and Drug Administration expands ’s indication to support identifying and monitoring patients for -targeting ’s therapies.
https://ow.ly/mAeh50WmGQw
Alzheimer's Association American Academy of Neurology (AAN) American College of Physicians (ACP)

The Food and Drug Administration has granted 510(k) clearance for the Felix NeuroAI Wristband (Fasikl, Minneapolis, MN), a novel transcutaneous peripheral…

07/08/2025

Our July issue is now live: Medical Editor Kyra O'Brien, MD of Penn Medicine presents a practical roadmap for implementing -targeting therapies in the clinic.

Read the new issue today: https://ow.ly/7uoO50WmAal
Alzheimer's Association American Academy of Neurology (AAN)

07/07/2025

The American Academy of Neurology (AAN) has issued a position statement calling for equitable care and inclusion for people with in , urging action on bias and barriers to access.
https://ow.ly/iHNM50Wktrx
Neurology Journal American College of Physicians (ACP)

The American Academy of Neurology (AAN) has released a new position statement calling for improved access to neurologic care and workplace inclusion for p…

07/03/2025

For diagnosing , CT and angiography fall short of accuracy thresholds, while clinical diagnosis remains the cornerstone according to data published in JAMA Neurology
https://ow.ly/tbWH50Wk4Ts
American Academy of Neurology (AAN) Neurocritical Care Society International Neuropalliative Care Society

CT perfusion and angiography imaging did not meet the necessary diagnostic accuracy thresholds in terms of sensitivity and specificity to serve as standal…

07/02/2025

Dr. Catherine Chu has been appointed to lead at Kennedy Krieger Institute and Johns Hopkins Medicine bringing expertise in , , and translational research.
https://ow.ly/Q8E350Wk4aJ
American Academy of Neurology (AAN) American Epilepsy Society Child Neurology Society

Catherine Chu, MD, MA, MMSc, has been named Vice President of Child Neurology of the Kennedy Krieger Institute and will also serve as Director of the Divi…

07/02/2025

Dr. Mark Stacy of the Medical University of South Carolina (MUSC) discusses emerging approaches to improve disease treatment in a new podcast episode, including , personalized medicine, and innovative trial design.
https://ow.ly/ge2R50WiqnX

The Michael J. Fox Foundation for Parkinson's Research American Academy of Neurology (AAN) International Parkinson and Movement Disorder Society

Mark Stacy, MD, William E. Murray Professor of Neurology, Medical University of South Carolina, Charleston, SC, discusses the evolving therapeutic landsca…

07/02/2025

Imaavy ( ) shows comparable or greater symptom control and improvement compared with other FcRn blockers in data presented at .
https://ow.ly/X5o050WjonW

Johnson & Johnson Myasthenia Gravis Foundation of America, Inc. American Academy of Neurology (AAN)

Results of an indirect treatment comparison (ITC) demonstrated that Imaavy (nipocalimab-aahu; Johnson & Johnson, New Brunswick, NJ) treatment was asso…